Brief: Biolife Solutions Collaborates With Seattle Children's To Improve Viral Vector And Cell And Gene Therapy Manufacturing
04/01/2022 14:43
Jan 4 (Reuters) - BioLife Solutions Inc BLFS.O :
* BIOLIFE SOLUTIONS COLLABORATES WITH SEATTLE CHILDREN'S TO
IMPROVE VIRAL VECTOR AND CELL AND GENE THERAPY MANUFACTURING
Source text for Eikon: ID:nPn5XNvxRa
Further company coverage: BLFS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on BioLife Solutions
See all newsFreshworks gains ahead of S&P SmallCap 600 inclusion
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: S&P Dow Jones Indices Freshworks Set To Join S&P Smallcap 600
BioLife Solutions, Inc. reports results for the quarter ended June 30 - Earnings Summary